Home › Funds › EULAV Asset Management › EXEL

EULAV Asset Management position in EXEL

EXELIXIS INC · Health Care

EULAV Asset Management reported holding 432,060 shares of EXEL (EXELIXIS INC) in its Q3 2026 13F filing — a position valued at US$25.2M, representing 0.91% of its reported portfolio and ranking #40 among its reported holdings. EULAV Asset Management has disclosed EXEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)432.06K sh
Reported value held$25.24M
Portfolio Weight0.91%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EULAV Asset Management's EXEL position evolved

EULAV Asset Management first disclosed a stake in EXEL in Q3 2023 at 650,000 shares (US$14.2M). The position peaked in Q2 2025 at 595,067 shares, worth US$26.2M. Across 13 filings, EULAV Asset Management increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 432,060 shares valued at US$25.2M — a reduction of -43,983 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 650.00K $14.20M New
Q4 2023 650.00K $15.59M Hold
Q1 2024 610.00K $14.48M Reduce
Q2 2024 545.00K $12.25M Reduce
Q3 2024 500.00K $12.97M Reduce
Q4 2024 480.00K $15.98M Reduce
Q1 2025 530.00K $19.57M Add
Q2 2025 595.07K $26.23M Add
Q3 2025 570.05K $23.54M Reduce
Q4 2025 535.04K $23.45M Reduce
Q1 2026 492.04K $21.10M Reduce
Q2 2026 476.04K $25.90M Reduce
Q3 2026 432.06K $25.24M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EXEL and 13F data

EXEL (EXELIXIS INC) is a Health Care company. 41 other funds we track also report a position in EXEL — the largest reported positions include Renaissance Technologies (US$747.2M), Farallon Capital Management (US$732.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$732.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EXEL

All EXEL fund holders →

FAQ

How long has EULAV Asset Management held EXEL?

EULAV Asset Management has disclosed EXEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EULAV Asset Management's current position in EXEL?

As of Q3 2026, EULAV Asset Management holds 432.06K shares of EXEL (EXELIXIS INC), valued at $25.24M, representing 0.91% of its reported portfolio and ranking #40.

Has EULAV Asset Management been buying or selling EXEL?

In the latest 13F filing (Q3 2026), EULAV Asset Management reduced its position in EXEL. The position peaked in Q2 2025 at 595.07K shares.

Which other funds hold EXEL?

Other major institutional holders of EXEL include Renaissance Technologies, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.